Cara Therapeutics, Inc. (CARA): insider trading, Congress trades & who owns it

Insider signal
60/100
Insider buying · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$0
0 sellers · 12 months
Funds holding
—
13F filings
Congress trades
None
none in 2 years

Quiet on the insider front: nobody at Cara Therapeutics, Inc. bought or sold CARA shares in open-market trades this past year.

Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.

Want the full picture on CARA? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full CARA report — free account

Latest insider trades in CARA

FiledInsiderRoleTypeSharesPriceValueSource
Mar 4, 2025Posner ChristopherCEOSell583$4.75$3KSEC
Mar 4, 2025Terrillion ScottExecutive OfficerSell163$4.76$776SEC
Feb 6, 2025Posner ChristopherCEOSell372$4.72$2KSEC
Nov 6, 2024Posner ChristopherCEOSell3,668$0.29$1KSEC
Aug 2, 2024Posner ChristopherCEOSell4,149$0.35$1KSEC
May 6, 2024Posner ChristopherCEOSell3,936$0.75$3KSEC
Apr 9, 2024Goncalves JoanaExecutive OfficerSell2,753$0.83$2KSEC
Apr 9, 2024Terrillion ScottExecutive OfficerSell2,753$0.83$2KSEC
Mar 4, 2024Terrillion ScottExecutive OfficerSell3,293$0.89$3KSEC
Mar 4, 2024Posner ChristopherCEOSell5,834$0.89$5KSEC
Mar 4, 2024Goncalves JoanaExecutive OfficerSell3,293$0.89$3KSEC
Feb 12, 2024Posner ChristopherCEOSell35,575$0.53$19KSEC
Feb 5, 2024Posner ChristopherCEOSell4,981$0.55$3KSEC
Nov 3, 2023Posner ChristopherCEOSell3,796$1.22$5KSEC
Aug 4, 2023Posner ChristopherCEOSell4,307$3.07$13KSEC

Questions about CARA

Are insiders buying or selling CARA stock?

There were no open-market insider trades in CARA in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

Has any member of Congress traded CARA?

No congressional trades in CARA were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).